TRADING UPDATES: Yellow Cake And Asiamet Resources Plan Fundraises lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
LONDON TRADING UPDATES: Alliance Pharma 2020 Revenue Slips By 5%
Wed, 20th Jan 2021 17:40
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Alliance Pharma PLC - healthcare company - Expects see-through revenue for 2020 to be down 5% on the prior year at GBP137.5 million from GBP144.3 million reported for 2019, both on a reported basis and on a constant currency basis, reflecting the impact of the Covid-19 pandemic. Underlying pretax profit for 2020 is expected to be marginally ahead of market expectations. As we progress into 2021, we look forward to regaining the strong momentum and revenue growth of recent years, and to benefiting from the additional growth opportunities that Amberen brings into the group, said Chief Executive Peter Butterfield. The acquisition of Biogix has brought Amberen into Alliance Pharma, a brand for the relief of menopause symptoms. The acquisition cre
UK EARNINGS SUMMARY: Schroder AsiaPacific Outperforms Benchmark
Mon, 14th Dec 2020 17:47
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and Monday and not separately reported by Alliance News:
Schroder AsiaPacific Fund PLC - investment firm focused on capital growth through investment primarily in equities of companies located in the continent of Asia excluding the Middle East and Japan - Says net asset value per share ends September at 567.16 pence compared to 490.94p at the same point the year before. Net assets grows to GBP946.1 million from GBP822.2 million over 12-month period. Declares final dividend of 8.0p, down from 9.7p the year before. NAV total return 17.7% versus benchmark adding 12.3%. After a very hard year for financial markets, the company is in good shape and is ready to take advantage of the opportunities in the region over the coming years. You, as shareholders, are participating in a region with outstand